SCM
Soleus Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-108,598
| Closed | -$2.28M | – | 91 |
|
|
2024
Q2 | $2.28M | Sell |
108,598
-88,500
| -45% | -$1.86M | 0.2% | 77 |
|
|
2024
Q1 | $6.28M | Buy |
197,098
+151,350
| +331% | +$4.82M | 0.47% | 59 |
|
|
2023
Q4 | $927K | Sell |
45,748
-78,000
| -63% | -$1.58M | 0.1% | 63 |
|
|
2023
Q3 | $1.58M | Sell |
123,748
-95,400
| -44% | -$1.21M | 0.15% | 72 |
|
|
2023
Q2 | $3.96M | Sell |
219,148
-250,252
| -53% | -$4.52M | 0.44% | 56 |
|
|
2023
Q1 | $8.07M | Buy |
469,400
+214,700
| +84% | +$3.69M | 0.84% | 33 |
|
|
2022
Q4 | $5.66M | Buy |
+254,700
| New | +$5.66M | 0.81% | 35 |
|
|
2021
Q4 | – | Sell |
-120,900
| Closed | -$3.26M | – | 78 |
|
|
2021
Q3 | $3.26M | Buy |
120,900
+20,100
| +20% | +$542K | 0.51% | 48 |
|
|
2021
Q2 | $2.43M | Buy |
100,800
+14,700
| +17% | +$354K | 0.37% | 47 |
|
|
2021
Q1 | $3.74M | Buy |
+86,100
| New | +$3.74M | 0.67% | 28 |
|